This trust offers the following services:

• Acute services:
• Specialist colorectal surgeon on-call at all times
• On-site bowel stenting facilities

• Diagnostic and pre-operative services:
• On-site PET-CT facilities
• On-site Cardio-Pulmonary Exercise Testing (CPET) facilities
• Routine Genetic Testing for Lynch Syndrome

• Surgical services:
• On-site hepatobiliary surgical team
• On-site thoracic surgical team
• Robotic surgery

• Advanced disease services:
• Dedicated Specialist Advanced Nurse
• Dedicated Specialist Advanced MDT
• Dedicated Specialist Advanced Outpatient Clinic
• Complex vascular reconstruction
• Distal sacrectomy
• High sacrectomy
• Extended lymphadenectomy

• Support service facilities:
• Dedicated nurses for ERAS services
• 7-day access to face-to-face palliative care services

All Patients:	Trust	Network	National
Number of patients in Audit	484	2258	35779
Case ascertainment (%)	Good	Good	Good
Data completeness of:
– Pre-treatment TNM (%)	81	79	86
– Performance status (%)	99	92	89

Patients having major resection:	Trust	Network	National
Number of patients in Audit	265	1187	19631
ASA grade 1 (%)	4	8	9
ASA grade 2 (%)	65	52	53
ASA grade 3 (%)	29	30	31
ASA grade 4+ (%)	2	2	2
ASA grade not recorded (%)	N/A	8	4
Data completeness of:
7 Audit items for risk-adjustment (%)	100	89	87

All Patients:	Trust	Network	National
Number of patients in Audit	484	2258	35779
Seen by Clinical Nurse Specialist (%)	90	94	88

Patients having major resection:	Trust	Network	National
Number of patients in Audit	265	1187	19614
Distant metastases (%)	10	5	5
Urgent or emergency surgery (%)	19	14	15
At least 12 lymph nodes excised (%)	82	85	84
Laparoscopic surgery attempted (%)	77	71	72
Risk-adjusted length of stay > 5 days (%)	54	56	55

Patients having major resection for stage III colon cancer:	Trust	Network	National
Number of patients in audit	155	N/A	10747
Adjuvant chemotherapy (%)	69	N/A	62

Patients receiving chemotherapy after major resection for stage III colon cancer:	Trust	Network	National
Number of patients in audit	138	N/A	6608
Severe acute toxicity after adjuvant chemotherapy (%)	22	N/A	22

Patients having major resection:	Trust	Network	National
Number of patients in Audit	64	N/A	4251
Neoadjuvant therapy (%)	21	N/A	33
Circumferential resection margin: Recorded (%)	98	94	89
Circumferential resection margin: Negative (%)	88	88	83
Rectal volume	58	N/A	4377

Patients in APER/Hartmanns estimate:	Trust	Network	National
Number of patients in APER/Hartmanns estimate	241	1284	19644
APER/Hartmanns (%)	46	43	37